Cargando…
Antioxidant and Anti-Inflammatory Effects of Oral Supplementation with a Highly-Concentrated Docosahexaenoic Acid (DHA) Triglyceride in Patients with Keratoconus: A Randomized Controlled Preliminary Study
A prospective, randomized, single-center preliminary study was performed in patients with keratoconus stages I–III (Amsler–Krumeich), who received a high rich docosahexaenoic acid (DHA) (1000 mg/day) supplement for 3 months versus untreated patients. One eye per patient was evaluated. Thirty-four pa...
Autores principales: | Peris-Martínez, Cristina, Piá-Ludeña, José Vicente, Rog-Revert, María José, Fernández-López, Ester, Domingo, Joan Carles |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10005296/ https://www.ncbi.nlm.nih.gov/pubmed/36904299 http://dx.doi.org/10.3390/nu15051300 |
Ejemplares similares
-
Antioxidant Activity and Neuroprotective Role of Docosahexaenoic Acid (DHA) Supplementation in Eye Diseases That Can Lead to Blindness: A Narrative Review
por: Lafuente, María, et al.
Publicado: (2021) -
Effects of Oral Supplementation with Docosahexaenoic Acid (DHA) plus Antioxidants in Pseudoexfoliative Glaucoma: A 6-Month Open-Label Randomized Trial
por: Romeo Villadóniga, Stéphanie, et al.
Publicado: (2018) -
Supplementation with high-content docosahexaenoic acid triglyceride in attention-deficit hyperactivity disorder: a randomized double-blind placebo-controlled trial
por: Rodríguez, Celestino, et al.
Publicado: (2019) -
Changes of Erythrocyte Fatty Acids after Supplementation with Highly Concentrated Docosahexaenoic Acid (DHA) in Pediatric Cystic Fibrosis: A Randomized Double-Blind Controlled Trial
por: Ayats-Vidal, Roser, et al.
Publicado: (2023) -
Inadequate Content of Docosahexaenoic Acid (DHA) of Donor Human Milk for Feeding Preterm Infants: A Comparison with Mother’s Own Milk at Different Stages of Lactation
por: Castillo, Félix, et al.
Publicado: (2021)